Efficacy and Safety of the Utilization of Dipeptidyl Peptidase IV Inhibitors in Diabetic Patients with Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials
Moeber M Mahzari,1– 3,* Muhannad Qirnas Alqirnas,1,2,4,* Moustafa S Alhamadh,1– 3 Faisal Alrasheed,1,2 Abdulrahman Yousef Alhabeeb,1,2 Wedad Al Madani,5 Hussain Aldera1,2 1College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 2King Abdulla...
Main Authors: | Mahzari MM, Alqirnas MQ, Alhamadh MS, Alrasheed F, Alhabeeb AY, Al Madani W, Aldera H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-03-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-and-safety-of-the-utilization-of-dipeptidyl-peptidase-iv-inhi-peer-reviewed-fulltext-article-DMSO |
Similar Items
-
Dipeptidyl peptidase IV and its implication in cancer
by: Yarini M Arrebola, et al. -
Dipeptidyl peptidase IV (DDP IV) in NASH patients
by: Yasemin H. Balaban, et al.
Published: (2007-10-01) -
Identification and Characterization of Dipeptidyl Peptidase-IV Inhibitory Peptides from Oat Proteins
by: Wei Wang, et al.
Published: (2022-05-01) -
The effect of dipeptidyl peptidase IV on disease-associated microglia phenotypic transformation in epilepsy
by: Zhicheng Zheng, et al.
Published: (2021-05-01) -
Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature
by: Yosuke Mai, et al.
Published: (2018-04-01)